topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
Published 1 year ago • 49 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
4:27
the role of immune checkpoint inhibitors in mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
4:44
immunotherapy in mds
-
3:10
the role of ngs in mds diagnosis
-
4:48
managing and treating mds
-
3:22
what is "mds"? (myelodysplastic syndromes)
-
7:54
patient/caregiver stories - living with mds
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
1:30
the prognostic value of patient-reported outcomes in mds
-
5:42
immune checkpoint inhibitors in mds and aml
-
2:04
state-of-the-art treatment for hr-mds
-
2:43
novel therapies in the future of mds treatment
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:16
current and future treatment approaches for hr-mds
-
1:16
state of the art: mds
-
1:53
immuno-oncology paving the way in mds
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:22
key advances in mds management
-
1:04
the future of mds management
-
3:11
clinical characteristics of h-mds